A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs. The New York Times By GINA KOLATA from NYT Times Insider https://ift.tt/2OeDtS3
Drugs (Pharmaceuticals), Health Insurance and Managed Care, Praluent (Drug), Repatha (Drug)
Comments
Post a Comment